Table 2.
DCIS | IDC | |||
---|---|---|---|---|
Low/intermediate grade | High-grade | Low/intermediate grade | High-grade | |
ESR1 | 16 | 15 | 13 | 25 |
EGFR | 5 | 10 | 0 | 4 |
FGFR1 | 32 | 55 | 27 | 38 |
ADAM9 | 58 | 45 | 67 | 50 |
IKBKB | 37 | 40 | 47 | 38 |
PRDM14 | 11 | 40 | 33 | 29 |
MTDH | 53 | 65 | 47 | 83 |
MYC | 42 | 65 | 47 | 63 |
CCND1 | 53 | 40 | 27 | 42 |
EMSY | 11 | 20 | 33 | 33 |
CDH1 | 21 | 15 | 7 | 25 |
TRAF4 | 42 | 65 | 33 | 58 |
CPD | 21 | 40 | 53 | 33 |
MED1 | 42 | 50 | 40 | 29 |
HER2 | 21 | 65 | 33 | 33 |
CDC6 | 42 | 55 | 47 | 42 |
TOP2A | 47 | 45 | 47 | 29 |
MAPT | 16 | 35 | 7 | 21 |
BIRC5 | 26 | 30 | 13 | 13 |
CCNE1 | 0 | 15 | 7 | 4 |
AURKA | 0 | 25 | 7 | 8 |
DCIS ductal carcinoma in situ, IDC invasive ductal carinoma